Having trouble accessing articles? Reset your cache.

XenoPort up on arbaclofen placarbil plans

XenoPort Inc. (NASDAQ:XNPT) gained $1.35 (22%) to $7.55 on Monday after

Read the full 116 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE